Intracellular membrane transport is a key factor of controlling cellular metabolism and survival. Vesicular delivery of membranes and various proteins to the specific cell sites and organs at different stages of the cell cycle and during the performance of different cell functions is essential for the maintenance of normal cell homeostasis. In this regard, Rab GTPases are one of the most important regulators of endocytic membrane transport in eukaryotic cells during cell division. Both activating and inactivating mutations in Rab genes have been associated with human diseases such as neurological disorders and cancer, while altered Rab expression has been associated with disease progression. Significant research is still needed to understand tumor gene expression, mutations, and drug susceptibility.
Rab proteins form the largest family of small GTPases and control different stages of intracellular membrane transport. These proteins have already been shown to control cell apoptosis, adhesion, division, survival, and migration by regulating various intracellular signaling pathways. Regulation of these processes usually occurs by the recruitment of Rab protein effectors and other regulatory proteins that control the interaction of Rab proteins with endocytic membranes and determine the activity of these organs in cells. Therefore, changes or disorders in the regulation of Rab proteins and their effectors are often associated with many human diseases, including neurodegeneration, immune diseases, infections, Parkinson's disease, and cancer. Although the mediation of Rab proteins in the maintenance and regulation of vital functions important to the cell is a highly relevant scientific topic, the functions of all Rab proteins have not yet been thoroughly investigated. It is important to emphasize that knowledge of altered intracellular dynamics of Rab GTPases and intercellular transport disorders at the molecular level may contribute to the development of new cancer therapy strategies.
According to recent research, the proteins Rab11 and Rab35, which belong to the Rab GTPase family, have been recognized as oncogenes [1, 2]. Also, due to the association of these proteins with the regulation of many important cellular functions, including cell division, proliferation, invasiveness, and migration, Rab proteins are a targeted object of study in cancer cell models. Despite studies on the regulation of Rab11 and Rab35 endosomes, it is not clear whether these proteins can function synergistically. Based on the recommendations from other scientific groups studying these regulators [3], it is important to identify interactions and compensatory mechanisms between these proteins in regulating cell-important processes, such as cell division, proliferation, migration, and invasiveness, the dysregulation of which, may influence cancer and promote tumorigenicity. Therefore, the aim of this study was to investigate the functions of Rab11 and Rab35 in regulating the last stage of cell division, - cytokinesis, which upon dysregulation, might influence phenotypic alterations of cancer cells. As well as to complement previous studies, while getting more insights of alternating cellular functions upon Rab11 and Rab35 genes downregulation.